BlackRock Fund Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$16.2M	Buy	305,848 +36,842	+14%	+$2.1M	﹤0.01%	2296
2016 Q3	$16.3M	Buy	269,006 +17,849	+7%	+$1.11M	﹤0.01%	2174
2016 Q2	$16.5M	Buy	251,157 +11,135	+5%	+$707K	﹤0.01%	2129
2016 Q1	$13.6M	Buy	240,022 +987	+0.4%	+$111K	﹤0.01%	2199
2015 Q4	$56.2M	Sell	239,035 -11,759	-5%	-$2.56M	0.01%	1395
2015 Q3	$39.7M	Buy	250,794 +8,140	+3%	+$2.3M	0.01%	1572
2015 Q2	$91.8M	Sell	242,654 -5,272	-2%	-$2.09M	0.02%	1066
2015 Q1	$104M	Buy	247,926 +25,144	+11%	+$8.99M	0.02%	969
2014 Q4	$61M	Buy	222,782 +20,500	+10%	+$5.1M	0.02%	1322
2014 Q3	$39.3M	Sell	202,282 -1,568	-0.8%	-$342K	0.01%	1515
2014 Q2	$49.9M	Sell	203,850 -19,487	-9%	-$4.4M	0.01%	1392
2014 Q1	$59.2M	Buy	223,337 +13,410	+6%	+$5.13M	0.02%	1289
2013 Q4	$76.2M	Buy	209,927 +10,869	+5%	+$4.19M	0.02%	1054
2013 Q3	$106M	Buy	199,058 +25,596	+15%	+$8.78M	0.04%	706
2013 Q2	$40.6M	Buy	+173,462	New	+$34.2M	0.01%	1378